NASDAQ:MTP - Midatech Pharma Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.1506 0.00 (0.00 %) (As of 01/18/2019 04:00 PM ET)Previous Close$0.1506Today's Range$0.1505 - $0.1752-Week Range$0.12 - $1.80Volume234,598 shsAverage Volume292,646 shsMarket Capitalization$4.74 millionP/E Ratio-0.21Dividend YieldN/ABeta2.15 ProfileDiscussionChartFinancialsHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Midatech Pharma PLC, a specialty pharmaceutical company, focuses on developing and commercializing products in oncology and immunotherapy in the United States and the United Kingdom. The company operates through two segments, Pipeline Research and Development; and Commercial. Its products include Zuplenz, an oral soluble film for moderately emetogenic chemotherapy-induced nausea and vomiting, radiotherapy-induced nausea and vomiting, and post-operative nausea and vomiting; Gelclair, an oral gel barrier device indicated for the management and relief of pain due to oral mucositis; Oravig, an orally dissolving buccal tablet for oral thrush; and Soltamox, an oral liquid solution of tamoxifen citrate, for the treatment and prevention of breast cancer. Midatech Pharma PLC is collaborating with universities and pharmaceutical companies to develop its platform technologies into a range of products. Midatech Pharma PLC was founded in 2000 and is headquartered in Abingdon, the United Kingdom. Receive MTP News and Ratings via Email Sign-up to receive the latest news and ratings for MTP and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:MTP Previous Symbol CUSIPN/A Webmidatechgroup.com Phone44-0-12-3588-8300Debt Debt-to-Equity Ratio0.26 Current Ratio3.24 Quick RatioN/APrice-To-Earnings Trailing P/E Ratio-0.21 Forward P/E Ratio-0.58 P/E GrowthN/A Sales & Book Value Annual Sales$9.79 million Price / Sales0.47 Cash FlowN/A Price / Cash FlowN/A Book Value$1.46 per share Price / Book0.10Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees85 Outstanding Shares30,540,000Market Cap$4.74 million OptionableNot Optionable Midatech Pharma (NASDAQ:MTP) Frequently Asked Questions What is Midatech Pharma's stock symbol? Midatech Pharma trades on the NASDAQ under the ticker symbol "MTP." When is Midatech Pharma's next earnings date? Midatech Pharma is scheduled to release their next quarterly earnings announcement on Monday, April 22nd 2019. View Earnings Estimates for Midatech Pharma. Has Midatech Pharma been receiving favorable news coverage? Headlines about MTP stock have trended neutral recently, according to InfoTrie Sentiment. The research group scores the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Midatech Pharma earned a media sentiment score of 0.3 on InfoTrie's scale. They also gave news stories about the company a news buzz of 6.0 out of 10, meaning that recent media coverage is somewhat likely to have an effect on the stock's share price in the next several days. Who are some of Midatech Pharma's key competitors? Some companies that are related to Midatech Pharma include Novelion Therapeutics (NVLN), Fibrocell Science (FCSC), Xenetic Biosciences (XBIO), Kaya (KAYS), Jaguar Health (JAGX), RegeneRx Biopharmaceuticals (RGRX), BENITEC BIOPHAR/S (BNTC), Soligenix (SNGX), RESAAS Services (RSASF), Gemphire Therapeutics (GEMP), Auris Medical (EARS), Prana Biotechnology (PRAN), THERAPIX BIOSCI/S (TRPX), Kazia Therapeutics (KZIA) and Endonovo Therapeutics (ENDV). Who are Midatech Pharma's key executives? Midatech Pharma's management team includes the folowing people: Mr. Nicholas John Robbins-Cherry, CFO, Company Sec. & Director (Age 50)Dr. Craig Richard Cook, CEO, COO & Director (Age 52)Mr. Rob Rainey FCA MBA MA, Head of Corp. Devel.Dr. Tim Sparey Ph.D., Chief Bus. OfficerMr. Justin Barry BSc (Hons.), MBIOL, CBIOL, QP, Head of Manufacturing How do I buy shares of Midatech Pharma? Shares of MTP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Midatech Pharma's stock price today? One share of MTP stock can currently be purchased for approximately $0.1506. How big of a company is Midatech Pharma? Midatech Pharma has a market capitalization of $4.74 million and generates $9.79 million in revenue each year. The company earns $-20,700,000.00 in net income (profit) each year or ($0.73) on an earnings per share basis. Midatech Pharma employs 85 workers across the globe. What is Midatech Pharma's official website? The official website for Midatech Pharma is http://midatechgroup.com. How can I contact Midatech Pharma? Midatech Pharma's mailing address is 65 INNOVATION DRIVE MILTON PARK, ABINGDON X0, OX14 4RQ. The company can be reached via phone at 44-0-12-3588-8300 or via email at [email protected] MarketBeat Community Rating for Midatech Pharma (NASDAQ MTP)Community Ranking: 2.9 out of 5 ( )Outperform Votes: 86 (Vote Outperform)Underperform Votes: 62 (Vote Underperform)Total Votes: 148MarketBeat's community ratings are surveys of what our community members think about Midatech Pharma and other stocks. Vote "Outperform" if you believe MTP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MTP will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/19/2019 by MarketBeat.com StaffFeatured Article: What factors cause inflation to rise?